Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2003
11/06/2003WO2003091413A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003WO2003091398A2 Compositions and methods for stem cell delivery
11/06/2003WO2003091387A2 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands
11/06/2003WO2003091386A2 A new family of picornaviruses
11/06/2003WO2003091285A1 Bispecific molecules for use in therapy and diagnosis of immune related and other diseases
11/06/2003WO2003091274A2 Use of alpha-s2 casein precursor-derived peptided
11/06/2003WO2003090781A1 Methods and devices for targeting a site in a mammal and for removing species from a mammal
11/06/2003WO2003090779A1 Remedy for lung cancer
11/06/2003WO2003090778A2 Dna vaccine combined with an inducer of tumor cell apoptosis
11/06/2003WO2003090776A1 Compositions and methods for diagnosis and treatment of cardiovascular disorders
11/06/2003WO2003090773A1 Treatment for weight loss
11/06/2003WO2003090772A1 Method for treating anxiety and mood disorders in older subjects
11/06/2003WO2003090676A2 Immunogenic agent therapy using plasmapheresis or exchange transfusion
11/06/2003WO2003090667A2 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
11/06/2003WO2003090600A2 Compositions and methods for the diagnosis and treatment of tumor
11/06/2003WO2003090529A2 Methods for identifying and using insecticides
11/06/2003WO2003090514A2 Adipocyte complement related protein zacrp14
11/06/2003WO2003090513A2 Bi-specific antigen-binding compositions and related methods
11/06/2003WO2003090512A2 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/06/2003WO2003063575A3 Endothelialization of vascular surfaces
11/06/2003WO2003062269A3 Corticotropin releasing factor receptor 2 agonists
11/06/2003WO2003054541A3 Inhibition of tristetraproline for protection of the heart from cardiac injuries
11/06/2003WO2003049694A3 Methods of therapy for non-hodgkin's lymphoma
11/06/2003WO2003048378A3 Methods and compositions for selectively cleaving dna containing duplex acids in a complex nucleic acid mixture
11/06/2003WO2003048327A3 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
11/06/2003WO2003046570A3 Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
11/06/2003WO2003034982A3 Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2003024399A3 Specific depletion of cd4+t cells
11/06/2003WO2003018749A3 Compositions and methods for generating antigen-binding units
11/06/2003WO2003016354A3 Recombinant anti-plasmodium falciparum antibodies
11/06/2003WO2003012069A3 Compositions and methods for generating chimeric heteromultimers
11/06/2003WO2003011878A3 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
11/06/2003WO2003011335A3 Polyvalent vaccine against diseases caused by papilloma viruses, method for the production and the use thereof
11/06/2003WO2003006506A3 Protease inhibitor conjugates and antibodies useful in immunoassay
11/06/2003WO2003003906A3 Diagnostic and screening methods for bladder cancer
11/06/2003WO2003002604A3 G protein coupled receptors and dna sequences thereof
11/06/2003WO2002083854A9 Antibodies to vla-1
11/06/2003WO2002083711A3 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
11/06/2003WO2002080960A3 Treatment of neuropathologies associated with expression of tnf-alpha
11/06/2003WO2002072600A3 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections
11/06/2003WO2002070657A8 93870, a human g-protein coupled receptor and uses therefor
11/06/2003WO2002066649A8 ANTI-INTERFERON-α ANTIBODIES
11/06/2003WO2002062945A3 Compositions and methods relating to lung specific genes and proteins
11/06/2003WO2002061105A3 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
11/06/2003WO2002061070A8 Environmentally regulated genes, involved in the virulence of streptococcus suis
11/06/2003WO2002059312A3 Cell adhesion proteins
11/06/2003WO2002053742A3 Proteins and nucleic acids encoding same
11/06/2003WO2002046475A3 Method of detecting and treating tuberous sclerosis complex associated disorders
11/06/2003WO2002044210A3 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
11/06/2003WO2002024891A9 B7-like molecules and uses thereof
11/06/2003WO2002024883A3 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
11/06/2003WO2001090157A8 98p7c3: homeodomain protein highly expressed in various cancers
11/06/2003WO2001080633A8 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/06/2003WO2000023569A8 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/06/2003US20030208797 Production of antibodies
11/06/2003US20030208792 A coat protein (CP) or a movement protein (MP) gene is replaced with a nuclear inclusion protease (NIa) expression cassette for the expression of a heterologous peptide in a tobacco ; for purposes of creating a vaccinevaccine
11/06/2003US20030208781 By immunization with any desired antigen
11/06/2003US20030208058 B7-like polypeptides and polynucleotides
11/06/2003US20030208055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030208054 Fc Receptors and polypeptides
11/06/2003US20030208053 Methods and compositions utilizing rad51
11/06/2003US20030208049 Comprising a molecule bound to Tumor necrosis factor (TNF) and methods of therapy utilising TNF and molecules active against TNF
11/06/2003US20030208048 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use
11/06/2003US20030208047 Relates to ligands which bind to human tumour necrosis factor alpha (TNF) to modify the biological activity
11/06/2003US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM)
11/06/2003US20030208041 Chloride channel polypeptides and nucleic acids, and their uses in obtaining compounds for preventing or treating a tick infestation
11/06/2003US20030208040 G-protein associated molecules
11/06/2003US20030207796 Specifically bind a carbohydrate target wherein sialic acid is linked at the nonreducing terminus of a glycoside to a galactose or galactosamine residue through an alpha 2-6 linkage are able to inhibit the conversion of human Factor X
11/06/2003US20030207469 Via immunoassay; low cross-reactivity with ephedrine and other compounds; antibody produced by a methylene dioxyphenyl derivative of agiven structure
11/06/2003US20030207447 Used to distinguish between arterial endothelial cells (arteries) and venous endothelial cells (veins)
11/06/2003US20030207446 Infectious papillomavirus pseudoviral particles
11/06/2003US20030207434 Phosphodiesterases
11/06/2003US20030207429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207426 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207425 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207423 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207422 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207421 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207420 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207419 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207418 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207417 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207416 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207415 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207414 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders
11/06/2003US20030207401 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207399 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207397 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207396 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207395 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207390 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207389 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207388 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207387 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
1 ... 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 ... 1494